Spectrum acquires full rights and intellectual property to Altair's RenaZorb in all fields Aug. 11, 2009
Kringle concludes dosing and safety evaluation in phase Ia trial of rhHGF in renal disease Aug. 6, 2009
Anti-inflammatory agent bindarit reduces MCP-1 excretion in patients with active lupus nephritis July 28, 2009
RSS